Dr Aganze Gloire-Aime Mushebenge, an independent research consultant from the Democratic Republic of the Congo, has graduated from UKZN with a PhD in Pharmaceutical Sciences for a study titled: Exploring the Structural Dynamics of SARS Coronavirus-2 and Identifying Potential 3-Chymotrypsin-Like Protease/Main Protease Inhibitors Using Computational Chemistry Methods.
The results of Mushebenge’s study, supervised by Dr Hezekiel M Kumalo and Dr Rene B Khan, are regarded as a major achievement in the field of global health.
His research focused on the molecular structure of SARS-CoV-2, targeting the 3-chymotrypsin-like protease, an enzyme critical to the virus’s replication process. Using computational chemistry, he identified potential inhibitors that could pave the way for effective COVID-19 treatments.
Mushebenge, who hails from Bukavu in the war-torn South Kivu province of the Democratic Republic of the Congo, described his academic journey as one shaped by resilience, faith and the drive to make a global impact. A passionate advocate for global health, his research extends beyond COVID-19 to neglected tropical diseases, with a commitment to addressing health inequities in underserved communities.
‘I aim to inspire the younger generation by showing that hard work, consistency, and determination can break barriers,’ said Mushebenge, referencing his faith and the guidance of mentors as the foundation of his success.
In addition to his research, Mushebenge has contributed to HIV and TB programmes in South Africa, trained healthcare professionals, and worked as a public health advocate in rural areas. His PhD accomplishment, he says, is a testament to perseverance and a commitment to improving health outcomes worldwide.
Words: Nombuso Dlamini
Photograph: Supplied